Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07045688

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

Efficacy of Vonoprazan Based Dual and Triple Therapy for Naive Patient With Helicobacter Pylori Infection

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

Conditions

Interventions

TypeNameDescription
DRUGEfficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infectionwe assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.
DRUGEfficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infectionwe assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.
DRUGEfficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infectionwe assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Timeline

Start date
2025-05-13
Primary completion
2025-11-25
Completion
2025-11-25
First posted
2025-07-01
Last updated
2025-07-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07045688. Inclusion in this directory is not an endorsement.